checkAd
    Startseite > Aktien > Genomic Vision > Nachrichten
    Genomic Vision Aktie
     
    EUR
    0,00 %
    0,00 EUR
    Letzter Kurs Lang & Schwarz
    ISIN: FR0011799907 · WKN: A110TM · Frankreich

    Neueste Nachrichten

    Genomic Vision Announces the Opening of a Receivership Proceedings
    17.11.23 · Business Wire (engl.) · Genomic Vision
    Genomic Vision: Financial Information for the Third Quarter of 2023
    14.11.23 · Business Wire (engl.) · Genomic Vision
    Genomic Vision Requests Receivership Proceedings
    03.11.23 · Business Wire (engl.) · Genomic Vision
    Genomic Vision Expands Its Replication Combing Assay Service Offering
    02.11.23 · Business Wire (engl.) · Genomic Vision
    Genomic Vision at the 30th Annual European Society of Gene and Cell Therapy (ESGCT) Congress in Brussels from 25 to 26 October 2023
    24.10.23 · Business Wire (engl.) · Genomic Vision
    Genomic Vision Reduces Replication Combing Assay Turnaround Time for Pharmaceutical Industry and Advances Drug Discovery and Oncology
    12.10.23 · Business Wire (engl.) · Genomic Vision
    Genomic Vision: First-Half 2023 Results
    29.09.23 · Business Wire (engl.) · Genomic Vision
    Genomic Vision Attended the 20th Edition of the European Drug Discovery Innovation Programme in Barcelona
    18.09.23 · Business Wire (engl.) · Genomic Vision
    Genomic Vision lance HexaCard, un nouveau service pour la caractérisation des lignées cellulaires transformées
    18.07.23 · globenewswire · Genomic Vision
    Genomic Vision Launches HexaCard, a New Service for Characterizing Transformed Cell Lines
    18.07.23 · Business Wire (engl.) · Genomic Vision
    Genomic Vision Announces the Issuance of the 3rd Tranche of Convertible Notes With Warrants (OCABSA) for €2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €30 Million
    23.06.23 · Business Wire (engl.) · Genomic Vision
    Genomic Vision conclut un accord de distribution avec CliniSciences
    22.06.23 · globenewswire · Genomic Vision